|
|
Cervomed Inc
CRVO's Fundamental analysis
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
|
Looking into Cervomed Inc growth rates, revenue grew
by 27.07 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 1398
Major Pharmaceutical Preparations industry recorded
growth of revenues by 9.72 %
Cervomed Inc faced net loss in contrast to the net income a year ago in III. Quarter 2024
• More on CRVO's Growth
|
|
Cervomed Inc
realized a net loss in trailing twelve months.
Cervomed Inc realized cash reduction of $ -0.31 per share in trailing twelve-month period.
|
| Company |
| - |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Company's Price to Sales ratio is at 6.91.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.28.
• More on CRVO's Valuation
|
|
|
|
|
Cervomed Inc
realized net loss in trailing twelve months.
Cervomed Inc realized cash outflow of $ -0.31per share in trailing twelve-month period.
|
| Company |
| - |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Company's Price to Sales ratio is at 6.91.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.28.
Cervomed Inc Price to Book Ratio is at 2 lower than Industry Avg. of 81.16. and higher than S&P 500 Avg. of 0.01
• More on CRVO's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
